Direct Comparison of Treatment Outcome Between the Botulinum Toxin and Calcitonin Gene-Related Peptide Monoclonal Antibody in Migraine Patients
Majed Mohammad Alabdali, Nazish Rafique, Deena A. AlDossary, Rahaf S. Alalloush, Haya A. AlHemli, Mohammad Zeerak, Rabia Latif, Lubna Ibrahim Al-Asoom, Ahmed Abdulrahman AlSunni, Ayad Mohammed Salem, Mohammed Alshurem, Dana Aljaafari, Shumaila Obaid, Aseel Alabdulhadi · 2024
Read Direct Comparison of Treatment Outcome Between the Botulinum Toxin and Calcitonin Gene-Related Peptide Monoclonal Antibody in Migraine Patients by Majed Mohammad Alabdali, Nazish Rafique, Deena A. AlDossary, Rahaf S. Alalloush, Haya A. AlHemli, Mohammad Zeerak, Rabia Latif, Lubna Ibrahim Al-Asoom, Ahmed Abdulrahman AlSunni, Ayad Mohammed Salem, Mohammed Alshurem, Dana Aljaafari, Shumaila Obaid, Aseel Alabdulhadi (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11614408.txt.
Description
Majed Alabdali and co-authors compare two preventive migraine treatments head to head in a 2024 study. Eighty chronic migraine patients at a Saudi hospital split into two groups of forty: one received botulinum toxin injections, the other an antibody drug against a pain related peptide. Scores for pain, disability, and headache impact were taken before and after nine months.
Both groups improved clearly on impact and pain scores. The antibody group improved a bit more, but the gap fell short of statistical significance. Headache was the most common side effect noted. The authors read the pair as near equals for prevention.
Catalog record
| CREATOR | Majed Mohammad Alabdali, Nazish Rafique, Deena A. AlDossary, Rahaf S. Alalloush, Haya A. AlHemli, Mohammad Zeerak, Rabia Latif, Lubna Ibrahim Al-Asoom, Ahmed Abdulrahman AlSunni, Ayad Mohammed Salem, Mohammed Alshurem, Dana Aljaafari, Shumaila Obaid, Aseel Alabdulhadi |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |